Passage Bio (PASG) Upgraded to Buy: Here's What You Should Know
Portfolio Pulse from
Passage Bio (PASG) has been upgraded to a Zacks Rank #2 (Buy) due to growing optimism about its earnings prospects. This upgrade suggests potential positive movement in PASG's stock price.
March 07, 2025 | 6:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Passage Bio (PASG) has been upgraded to a Zacks Rank #2 (Buy), indicating increased optimism about its earnings prospects. This upgrade could lead to a positive short-term impact on PASG's stock price.
The upgrade to a Zacks Rank #2 (Buy) reflects increased optimism about Passage Bio's earnings prospects. Such upgrades typically lead to positive investor sentiment and can result in a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100